Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.65
Bid: 2.50
Ask: 2.80
Change: -0.05 (-1.85%)
Spread: 0.30 (12.00%)
Open: 2.70
High: 2.70
Low: 2.65
Prev. Close: 2.70
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: London gets boost thanks to rate cut hopes

Mon, 20th May 2024 16:52

(Alliance News) - Stock prices in London closed higher on Monday, with investors optimistic that interest rate cuts might be around the corner.

The FTSE 100 index closed up 3.94 points at 8,424.20. The FTSE 250 ended up 123.43 points, 0.6%, at 20,873.33, and the AIM All-Share closed up 15.92 points, 2.0%, at 809.94.

The Cboe UK 100 ended up 0.1% at 840.87, the Cboe UK 250 closed up 0.6% at 18,250.48, and the Cboe Small Companies ended up 0.8% at 16,532.02.

In European equities on Monday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt ended up 0.3%.

Investors this week are eyeing Wednesday's inflation reading for the UK. It is expected to show that the rate of consumer price inflation moderated markedly to 2.1% in April, from 3.2% in March, according to FXStreet cited consensus.

If the reading comes in line with expectations, hopes for an interest rate cut from the Bank of England will climb.

Last week there was some good news from the US in terms of cooling inflation.

Swissquote Bank analyst Ipek Ozkardeskaya commented: "Equity bulls around the globe celebrated in style the softer-than-expected US CPI data last week. The global equity rally was further juiced by the expectation that a softer inflation in the US would not only allow the Federal Reserve to start cutting the rates this year, but also allow the other major central banks, like the European Central Bank and the Bank of England, to carry on with their plans to cut their own rates and – maybe – cut more than people think they could."

Hopes of an interest rate cut have prompted the price of gold higher, with the precious metal hitting a record high above USD2,450 an ounce earlier Monday.

Gold was quoted at USD2,423.50 an ounce at the London equities close Monday, up against USD2,407.63 at the close on Friday.

Higher gold prices pushed gold miner Fresnillo up 4.0% to the top of the FTSE 100 index.

The pound was quoted at USD1.2702 at the London equities close Monday, higher compared to USD1.2696 at the close on Friday. The euro stood at USD1.0862 at the European equities close Monday, lower against USD1.0866 at the same time on Friday. Against the yen, the dollar was trading at JPY156.14, higher compared to JPY155.53 late Friday.

In the FTSE 100, Airtel Africa rose 2.2%.

The Africa-focused telecommunications firm confirmed that its subsidiary Bharti Airtel International (Netherlands) BV has fully repaid a USD550 million bond in 5.35% guaranteed senior notes maturing on Monday.

In the FTSE 250 index, Kainos rose 17%.

The London-based IT service company said in the year ended March 31, statutory pretax profit rose 19% to GBP64.8 million from GBP54.3 million the year prior. Revenue increased 2.0% to GBP382.4 million from GBP374.8 million.

Kainos declared a final dividend of 19.1 pence per share, up 19% from 16.1p. Therefore, the total dividend paid for the year stands at 27.3p, up 14% from 23.9p.

Chief Executive Officer Russell Sloan commented: "Our latest results, record our 14th consecutive year of growth with disciplined execution in the current macro-economic climate.

On London's AIM, ValiRx shot up 23%.

ValiRx noted that the peptide nanoparticle formation Cytolytix received a Knowledge Transfer Voucher grant in conjunction with The Open University. Cytolytix Ltd is a partially-owned ValiRx subsidiary established to progress CLX001.

The life sciences company focused on early-stage cancer therapeutics and women's health highlighted that the assessment of formulation options for the triple negative breast cancer project CLX001 has progressed during the first quarter of 2024.

On the other hand, Haydale Graphene Industries closed down 11%.

The Carmarthenshire, Wales-based technology solutions company warned sales and earnings would miss City forecasts as an upturn in orders in the US was taking longer than hoped to materialise.

In a trading update for the year ending June, Haydale said it expects full-year sales of GBP4.7 million behind current market forecasts of GBP5.8 million. This would still be above last year's GBP4.3 million, Haydale said.

Adjusted earnings before interest, tax, depreciation and amortisation is expected to only be "marginally behind" market expectations, at a GBP3.2 million compared to forecasts for a GBP3.0 million loss.

Stocks in New York were higher at the London equities close, with the DJIA up 0.2%, the S&P 500 index up 0.4%, and the Nasdaq Composite up 0.7%.

Brent oil was quoted at USD83.65 a barrel at the London equities close Monday, up from USD83.61 late Friday.

In Tuesday's UK corporate calendar, there is a trading statement from Kingfisher, as well as Smiths Group.

The economic calendar for Tuesday has current account and trade balance data from the eurozone. There is also a PPI reading from Germany.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
20 May 2024 14:21

ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant

(Alliance News) - ValiRx PLC on Monday noted that the peptide nanoparticle formation Cytolytix received a Knowledge Transfer Voucher grant in conjunction with The Open University.

Read more
16 May 2024 16:29

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 May 2024 18:38

TRADING UPDATES: Vertu Motors ups dividend as hails record revenue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 May 2024 10:45

AIM WINNERS & LOSERS: Itim up on Majestic Wine contract renewal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.